CD274 and neoplasm: The tumor-derived exosomes can reprogram TRMs through TLR-2 and activate MYD88 and NF-kB signaling, inducing increased glycolysis and lactic acidosis, which leads to increased PD-L1 expression and immunosuppression (48, 52).